Human CD34+ Progenitor Cells from Mobilized Peripheral Blood, Positive Selection, 1 Million

Cryopreserved ampule of Human CD34 Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 1 million cells. Mobilized peripheral blood CD34 hematopoietic stem and progenitor cells are positively selected using a immunomagnetic CD34 microbead labeling system. Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using AO/PI. Cells are collected from healthy donors following IRB protocols.
Benefits: Obtain large quantities of CD34 from a donor, Certificate of analysis (CoA) provided for each lot purchased, Test negative for mycoplasma, bacteria, yeast, and fungi, HIV-1, Hepatitis B and Hepatitis C are not detected for all donors and/or cell lots.
Applications: CAR-T therapy development, iPSC generation, Autoimmune disease, Immunology, Cancer research. Manufactured by AllCells®